Ask the Expert: An Introduction to Clinical TrialsLive webinar held June 15, 2016, 2:00-3:00 pm EDT
Interview with Dr. Daniel Kaufer recorded April 19, 2016
EXPERT PRESENTER: Daniel Kaufer, MD
Dr. Daniel Kaufer received his undergraduate and medical school degrees at the University of Wisconsin-Madison. He then completed Neurology residency training at the University of Pittsburgh and fellowship training in Behavioral and Geriatric Neurology at the University of California at Los Angeles.
In 2005 he was a principal co-author of the initial core curriculum and certifying examination for Behavioral Neurology & Neuropsychiatry, and is the past-president of the Society for Behavioral and Cognitive Neurology. He is a Fellow of the American Academy of Neurology and the American Neuropsychiatric Association, and currently serves on the Scientific Advisory Council of the Lewy Body Dementia Association, the International FTD Registry Scientific Advisory Board, and the Alzheimer’s North Carolina Board of Directors.
He has published over 100 peer-reviewed journal articles, review papers, and book chapters. His principal research interests include developing more robust diagnostic approaches combining novel clinical assessments with state-of-the-art brain imaging methodology, and evaluating investigational therapeutic agents for Alzheimer’s and related dementias. As a translational cognitive neurologist, he is working to facilitate the transfer of neurocognitive disorder research into practice.
Dr. Kaufer has consulted for Janssen R&D, Takeda/Zinfandel and has received research support from TauRx, Navidea Biopharmaceuticals, Axovant and Neurim Pharmaceuticals.
Angela Taylor is LBDA’s Director of Programs and oversees all areas of LBDA’s mission-oriented activities, including programs and services for LBD families, educational programming, as well as advocacy and research initiatives.
A nationally-recognized LBD advocate, she serves on the federal Advisory Council on Alzheimer’s Research, Care and Services. She is also the liaison to LBDA’s Scientific Advisory Council.